E Fund Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $555K | Buy |
10,395
+3,471
| +50% | +$185K | 0.03% | 215 |
|
|
2025
Q1 | $280K | Buy |
+6,924
| New | +$280K | 0.01% | 323 |
|
|
2024
Q2 | – | Sell |
-13,899
| Closed | -$351K | – | 319 |
|
|
2024
Q1 | $351K | Sell |
13,899
-10,273
| -42% | -$259K | 0.02% | 252 |
|
|
2023
Q4 | $564K | Buy |
24,172
+14,744
| +156% | +$344K | 0.04% | 135 |
|
|
2023
Q3 | $477K | Buy |
9,428
+918
| +11% | +$46.4K | 0.04% | 126 |
|
|
2023
Q2 | $397K | Sell |
8,510
-830
| -9% | -$38.7K | 0.03% | 171 |
|
|
2023
Q1 | $357K | Sell |
9,340
-264
| -3% | -$10.1K | 0.03% | 201 |
|
|
2022
Q4 | $526K | Buy |
+9,604
| New | +$526K | 0.04% | 126 |
|